comprehensive -WSS

comprehensive

author：focus 2025-09-06 03:17:29 - browse：4

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： CRISPR base editing slashes cholesterol levels in monkeys

WSS

The United States is paying nearly triple for new Covid vaccines

Millions may soon lose Medicaid when they don't have to

Stop Congress from blocking public access to science

Will an HIV vaccine ever be a reality?

Will an HIV vaccine ever be a reality?

The thinking behind the controversial eating disorder chatbot Tessa

entertainment

comprehensive

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

The Karikó problem: Lessons for funding basic research

Hepatitis C has a cure — but many Americans still lack access to it

FDA approves first new drug developed for postpartum depression

Sports medicine is finally prioritizing gender equality

The United States is paying nearly triple for new Covid vaccines

Heart attack and stroke risk calculators need revising

Experts study whether long Covid risk adds up with each reinfection

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Wikipedia

Inside the rise of 'mukbang' eating videos

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Lawsuit highlights wrinkle for disputes over surprise medical bills

Congress extends some pandemic preparedness programs

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

FDA approves first new drug developed for postpartum depression

entertainment

hotspot

Wikipedia

explore